| Patent application number | Description | Published |
|---|
| 20090163067 | Cable connector - A cable connector includes a housing into which a cable may be inserted. A plurality of terminals are mounted on the housing and include an elastically-deformable arm portion with a free end section and a distal end section; and an actuator mounted on the housing and movable between a first operative position and a second operative position wherein the actuator urges the contact portion of each terminal towards the cable upon insertion of said cable into said insertion opening and movement of said actuator from said first operative position to said second operative position. | 06-25-2009 |
| 20090246976 | Rotary Connector - Rotary electrical connector comprising a ring-shaped outside terminal having a circular inner circumference portion, a ring-shaped inside terminal having a circular outer circumference portion, which is concentric with the inner circumference portion of the ring-shaped outside terminal; and a rotatable ring-shaped connection terminal electrically connecting the outside terminal with the inside terminal; wherein the connection terminal elastically deforms along a radial direction thereof, an outer circumference portion of the connection terminal abuting the inner circumference portion of the outside terminal and the outer circumference portion of the inside terminal. | 10-01-2009 |
| 20100075529 | TERMINAL ASSEMBLY AND FLAT CABLE CONNECTOR - A connector for connecting together two ends of flat flexible cable includes a base member and a cover member. The base member has a plurality of slots that receive a corresponding number of conductive terminals. The terminals have two upward bends in them near their midpoint and these bends are spaced apart longitudinally along the terminals so as to mate with exposed ends of the lengths of flat cable. Two projections serve as press arms to retain a cover in place upon the base member. The cover exerts a pressure on the cable ends and the terminals to provide a reliable electrical contact between them. | 03-25-2010 |
| 20100075541 | RELAY CONNECTOR FOR FLEXIBLE CABLES - A connector ( | 03-25-2010 |
| 20100120297 | Terminal Assemblies, Connectors And Manufacturing Thereof - Terminal assemblies, connectors and methods of manufacturing the terminal assemblies are provided such that a plurality of elongated terminals are arranged in parallel at a pre-defined pitch and are partially enclosed by a terminal holding member, and in which the terminals are separated from one another during a material removal process. | 05-13-2010 |
| 20110083889 | FPC-Based Relay Connector - A bridge connector for interconnecting two connectors mounted on circuit boards together includes a planar substrate that supports a length of flexible printed circuit, the substrate has engagement arms that are chamfered to act as male connector portions and be received within receptacle portions for the board connectors to effect a reliable connection between the two connectors. | 04-14-2011 |
| 20110143602 | INPUT/OUTPUT CONNECTOR WITH CAPACITIVE COUPLING MATING INTERFACE - A plug connector ( | 06-16-2011 |
| 20110159711 | CAPACITIVELY COUPLED CONNECTOR FOR FLEXIBLE PRINTED CIRCUIT APPLICATIONS - A FPC connector has an insulative housing with a general U-shape that defines an opening that receives a free end of a length of FPC. The housing has a base and two leg portions and the leg portions have engagement arms that hold engage the FPC free end when inserted into the connector housing opening. A cover of the connector housing has press members that press the FPC and dielectric barriers thereon into contact with contacts on a circuit board. | 06-30-2011 |
| 20110189867 | ELASTIC-CUSHIONED CAPACITIVELY-COUPLED CONNECTOR - A connector according to the present invention is equipped with an elastic member with elasticity, at least one terminal including a connecting conductor portion formed on one side of the elastic member and connected to a circuit side conductor portion electrically continuous with a circuit provided on a first flat circuit substrate, a first opposing conductor portion formed on another side of the elastic member and opposed to a second opposing conductor portion electrically continuous with a circuit provided on a second flat circuit substrate, and a linking conductor portion linking the connecting conductor portion and the first opposing conductor portion with each other so as to allow them to make relative movement, and a dielectric portion formed at least on one of the first opposing conductor portion | 08-04-2011 |
| 20110244734 | COMPONENT-TO-BOARD ELECTRICAL CONNECTOR - An electrical connector is provided with a plug portion having an upper surface on which electronic components can be disposed, and a receptacle portion for mounting on a circuit board. In the plug portion, a central recess is formed, which extends downwardly within the body of the receptacle portion so that the electronic components are disposed at least partially within the central recess. The plug portion has, on its lower surface side, plug side contacts that serve as electrical contacts with a terminal of the receptacle portion, and has a protruding portion for engaging the connector receptacle portion. The plug side contacts and the protruding portion are positioned outside of the central recess higher than a bottom plate portion which forms a bottom of the central recess. | 10-06-2011 |
| 20110275228 | CAPACITIVELY COUPLED CONNECTOR FOR ELECTRONIC DEVICE - An electrical connector is provided that includes a plug portion having an upper surface on which one electronic device is disposed, and a receptacle which is disposed on another electronic device. The plug portion has plug side contact conductors which are positioned separately from each other on a lower surface side of the plug portion. Between the plug side contact conductors which are positioned separately from each other, a capacitive coupling conductor is provided. The receptacle has a receptacle side contact conductors which are in contact with the plug side contact conductors. The plug side contact conductors and the receptacle side contact conductors have shapes corresponding to each other, and the receptacle side contact conductors retain the plug side contact conductors while the dielectric is interposed between the capacitive coupling. | 11-10-2011 |
| 20110279946 | CONNECTOR USING LIQUID DIELECTRIC FOR IMPROVED PERFORMANCE - A connector assembly utilizes improved capacitive coupling for connecting together electrical circuits on two substrates ( | 11-17-2011 |
| 20120094534 | CONNECTOR, CABLE ASSEMBLY, AND SEMICONDUCTOR TESTING DEVICE - The connector includes an enclosure including insertion holes formed therein, into which tip end portions of coaxial cables provided with signal terminals and with ground terminals arranged at parts of peripheries of the signal terminals are inserted, and auxiliary ground conductors, which are retained by the enclosure, are electrically connected to the ground terminals, and are arranged at other parts of the peripheries of the signal terminals. | 04-19-2012 |
| 20120295484 | MODULE SOCKET - The Present Disclosure is a module socket for mounting a module on a mounting member, in which the module socket has a first connector including a flat housing, a first conductive pattern arranged on the mating side surface of the housing, and a male terminal protruding from a surface of the first conductive pattern, and a flat second connector formed from plate-shaped metal and including a female terminal elastically interposing the male terminal, and in which either the first conductor or the second conductor is attached to the module and the other is attached to the mounting member. | 11-22-2012 |
| Patent application number | Description | Published |
|---|
| 20110178157 | MODULATION OF HSP47 EXPRESSION - Provided herein are compositions, methods and kits for modulating expression of target genes, particularly heat shock protein 47 (hsp47). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding hsp47, for example, the gene encoding human hsp47. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with hsp47 such as liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis. | 07-21-2011 |
| 20120142754 | MODULATION OF TIMP1 AND TIMP2 EXPRESSION - Provided herein are compositions, methods and kits for modulating expression of target genes, particularly of tissue inhibitor of metalloproteinase 1 and of tissue inhibitor of metalloproteinase 2 (TIMP1 and TIMP2, respectively). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding TIMP1 and TIMP2, for example, the gene encoding human TIMP1 and TIMP2. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with TIMP1 and TIMP2 including fibrotic diseases and disorders including liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis. | 06-07-2012 |
| 20130030034 | MODULATION OF TIMP1 AND TIMP2 EXPRESSION - Provided herein are compositions, methods and kits for modulating expression of target genes, particularly of tissue inhibitor of metalloproteinase 1 and of tissue inhibitor of metalloproteinase 2 (TIMP1 and TIMP2, respectively). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding TIMP1 and TIMP2, for example, the gene encoding human TIMP1 and TIMP2. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with TIMP1 and TIMP2 including fibrotic diseases and disorders including liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis. | 01-31-2013 |
| Patent application number | Description | Published |
|---|
| 20110257249 | DRUG CARRIERS - Compositions that can include a cationic polymeric carrier, targeting agent, and therapeutic agent are disclosed herein. The therapeutic agent may have a therapeutic activity such as inhibiting fibrosis within a target organ or tissue or inhibiting the growth of a cancer cell. | 10-20-2011 |
| 20120076852 | DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS - An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited. | 03-29-2012 |
| 20120189691 | DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS - An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited. | 07-26-2012 |
| 20120269886 | THERAPEUTIC AGENT FOR PULMONARY FIBROSIS - Disclosed are: a substance transfer carrier to an extracellular matrix-producing cell in the lung, which comprises a retinoid; a therapeutic agent for pulmonary fibrosis, which utilized the carrier; and a preparation kit of the therapeutic agent. | 10-25-2012 |
| 20130011336 | IMAGING AGENTS OF FIBROTIC DISEASES - Agents and methods for imaging a cell and/or a portion of tissue characterized by fibrosis, as well as to agents and methods for determining and/or diagnosing fibrotic diseases are disclosed herein. Also disclosed herein are polymer conjugates that can include a detectable label, a retinoid and a polymer. The polymer conjugates can be used to image a portion of tissue, deliver a detectable label to a portion of tissue or a cell and/or diagnosis a condition or disease. | 01-10-2013 |
| Patent application number | Description | Published |
|---|
| 20110104255 | THERAPEUTIC AGENT FOR FIBROID LUNG - Disclosed are: a substance transfer carrier to an extracellular matrix-producing cell in the lung, which comprises a retinoid; a therapeutic agent for fibroid lung, which utilized the carrier; and a preparation kit of the therapeutic agent. | 05-05-2011 |
| 20110229558 | AGENT FOR TREATING MYELOFIBROSIS - Disclosed is a substance delivery carrier for an extracellular matrix-producing cell in the bone marrow, which comprises a retinoid. Also disclosed is an agent for treating myelofibrosis by utilizing a substance capable of regulating the activity or proliferation of an extracellular matrix-producing cell in the bone marrow. | 09-22-2011 |
| 20120328694 | THERAPEUTIC AGENT FOR FIBROID LUNG - Disclosed are: a substance transfer carrier to an extracellular matrix-producing cell in the lung, which comprises a retinoid; a therapeutic agent for fibroid lung, which utilized the carrier; and a preparation kit of the therapeutic agent. | 12-27-2012 |
| 20130011464 | DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS - An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited. | 01-10-2013 |
